Neoadjuvant immunochemotherapy for resectable esophageal cancer: A study on efficacy and safety. Biomol Biomed [Internet]. 2025 Apr. 1 [cited 2025 Apr. 19];. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/11806